Richter-Helm offers highly specialised contract development and manufacturing services for the pharmaceutical and biotechnological industries. Additionally, Richter-Helm is seeking for interesting biopharmaceutical development projects for its own pipeline and for co-development with partners.
The roots of Richter-Helm go back to their pilot plant in Hannover, Germany, where they started the production of plasmid DNA according to GMP in 1997. One of the first actions of the new shareholders has been to increase the number of employees and to invest again heavily in space and equipment. Thus, the Hannover-facility will become another state-of-the-art facility operated by Richter-Helm with fermentation capacities up to 200 L.
Apart from the Hannover-based facility Richter-Helm operates one of the most modern biotechnology facilities in Europe. This production plant in Bovenau, near Hamburg was designed as a multipurpose facility for the manufacturing of recombinant proteins, plasmid DNA and microbial vaccines. Covering more than 4,500sqm, this multipurpose cGMP production plant meets FDA and EMEA requirements.
The third working site of Richter-Helm is located in Hamburg. This branch specialises in process development and analytical development, including the development of bioassays.
Comparable equipment allows easy transfer from one unit to the other. In all sites the capacity can be planned flexible depending on the actual needs. This flexibility allows Richter-Helm to choose the ideal site, respectively the ideal combination of sites for every project.
After having offered contract manufacturing services for more than 20 years now and following the long term strategy of Gedeon Richter Plc and HELM AG Richter-Helm starts to build up an own development pipeline of biopharmaceuticals. Managed by strong interdisciplinary teams consisting of specialists from Richter-Helm, Gedeon Richter and HELM AG covering all relevant steps of the development this new part of Richter Helm creates also additional opportunities in terms of in- and out-licensing for third parties.